Assessing Study Quality and Bias in Prognosis Research on Rehabilitation in Chronic Pain Using the QUIPS Tool

Researchers performed a systematic review to synthesize evidence on prognostic factors for physical functioning after multidisciplinary rehabilitation in patients with chronic musculoskeletal pain and used a tool, QUIPS, which was developed specifically for evaluation of study quality of prognostic studies.

Continue reading

'Alexa, I’m in pain': Tool Delivers Mindfulness-Based Techniques to Chronic Pain Sufferers

Researchers at Penn State are developing a way to deliver on-demand, guided mindfulness practices via Amazon Alexa to patients experiencing chronic pain. Through their method, a smart assistant will provide Mindfulness-Based Stress Reduction (MBSR) practices to individuals in their homes. 

Continue reading
Topics:

Anterior Nucleus of Paraventricular Thalamus Mediates Chronic Mechanical Hyperalgesia

Pain-related diseases are the top leading causes of life disability. Identifying brain regions involved in persistent neuronal changes will provide new insights for developing efficient chronic pain treatment. Here, we showed that anterior nucleus of paraventricular thalamus (PVA) plays an essential role in the development of mechanical hyperalgesia in neuropathic and inflammatory pain models in mice.  

Continue reading

AAMC Statement on House Bill to Support New Residency Positions, Including for Pain Management

Association of American Medical Colleges President and CEO Darrell G. Kirch, MD, issued a statement about the Opioid Workforce Act of 2019 (H.R. 2439), which was introduced in the U.S. House of Representatives and would support new addiction medicine, addiction psychiatry, or pain management residency positions. 

Continue reading

FDA Announces Public Meeting to Discuss Safety and Utility of Higher-Dose Opioid Analgesics

FDA is seeking public input on the clinical utility and safety concerns associated with the higher range of opioid analgesic dosing (both in terms of higher strength products and higher daily doses) in the outpatient set...
Continue reading
Topics:

AMA Webinar: Thriving in Practice - Staywell Performance Story

Register here for a webinar on May 22 at 12 pm CT to hear a long-time physician share her practice's journey through the phases of transformation and how both the struggles and the triumphs have prepared the practice tea...
Continue reading
Topics:

Internet-Based Pain Coping Skills Training for Patients With Lupus

Background and Significance: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that impacts multiple organ systems. SLE results in a variety of challenging symptoms, including flare-ups and periods of remission that are unpredictable, and it is a complex disease to manage clinically. Because of these factors, SLE often has a major impact on patients' quality of life. Notably, SLE is often associated with pain, fatigue, emotional symptoms like anxiety and depression, and disability. Because of the relatively young average age of SLE onset, many patients must navigate these challenges while maintaining work and / or caring for young children.
Continue reading

Prospective Data Demonstrates Effective Pain Relief and Improved Function Using Medtronic's Evolve(SM) Workflow with Spinal Cord Stimulation

Medtronic today announced primary endpoint (3-month) results of the Vectors Post Market Clinical Study that demonstrated effective pain relief and improved function in patients with chronic intractable back and leg pain treated with spinal cord stimulation (SCS) utilizing the EvolveSM workflow

Continue reading
Topics:
SCS

E/M Services and Procedures on the Same Day: When Can You Report Both?

According to CPT, both an Evaluation and Management (E/M) service and a procedure code can be reported if the patient's condition requires a significant, separately identifiable E/M service. "Significant" implies that th...
Continue reading
Topics:

FDA MedWatch Safety Alert: Ketorolac Tromethamine Injection by Sagent Pharmaceuticals: Recall - Due to Lack of Sterility Assurance

Sagent Pharmaceuticals, announced the voluntary nationwide recall of Lot Number M813513 of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL). This product was manufactured by Zydus (Cadila Healthcare Limited) and distributed by Sagent Pharmaceuticals, Inc. Sagent has initiated this voluntary recall of Ketorolac Tromethamine Injection, USP to the to the user level due to microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.  

Continue reading